General Information of Drug (ID: DMNNDMA)

Drug Name
Telomelysin
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 2 [1]
Merkel cell carcinoma 2C34 Phase 2 [1]
Cross-matching ID
TTD ID
D0I3VV
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)